Anti-Bacterial Agents Clinical Trial
Official title:
The Effects of Antibiotic Combinations on Mesenchymal Stem Cells Derived From Apical Papilla
The purpose of this study was to evaluate the indirect effects of antibiotic combinations. SCAP viability, proliferation and apoptosis of the cells were evaluated. Osteocalcin (BGLAP), dentin sialo phosphoprotein (DSPP) and alkaline phosphatase (ALPP) gene expression levels were also evaluated.
The purpose of this study was to evaluate the indirect effects of triple (TAP- ciprofloxacin, metronidazole and minocycline), double (DAP- ciprofloxacin and metronidazole) and modified triple antibiotic pastes (mTAP- ciprofloxacin, metronidazole and cefaclor) on mesenchmal stem cells derived from apical papilla (SCAP). SCAP were isolated from the impacted third molar teeth of the young adults. TAP, DAP and mTAP treatment (14-day medication and 28-day medication) were applied on SCAP and viability, proliferation and apoptosis of the cells were evaluated after four weeks. Osteocalcin (BGLAP), dentin sialo phosphoprotein (DSPP) and alkaline phosphatase (ALPP) gene expression levels were also evaluated. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05846399 -
CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
|
Phase 4 | |
| Completed |
NCT03349567 -
Improving Antimicrobial-Prescribing in Emergency Departments
|
N/A | |
| Completed |
NCT04172207 -
Antibiotic, Gingival-biopsy, and Oral-smear Samples.
|
||
| Completed |
NCT05261152 -
S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
|
Phase 4 | |
| Terminated |
NCT03089697 -
Phase IIa Clinical Study of N-Rephasin® SAL200
|
Phase 2 | |
| Completed |
NCT03037112 -
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
|
N/A | |
| Recruiting |
NCT03440216 -
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
|
N/A | |
| Completed |
NCT03408457 -
Influence of Perioperative Fluid Balance on Serum Concentrations of Antibiotics and Surgical Site Infections
|
||
| Completed |
NCT04872400 -
Acute Application of Antibiotic Powder in Open Fracture Wounds
|
Phase 4 | |
| Completed |
NCT03114358 -
Carbapenems De-escalation as Antimicrobial Stewardship
|
N/A | |
| Completed |
NCT03245879 -
Antibiotic Stewardship in Small Hospitals
|
N/A | |
| Recruiting |
NCT05925309 -
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
|
N/A | |
| Completed |
NCT03098485 -
Healthy Patients & Effect of Antibiotics
|
N/A | |
| Completed |
NCT00272155 -
An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice
|
Phase 1/Phase 2 | |
| Completed |
NCT03280147 -
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
|
Phase 3 | |
| Completed |
NCT03446053 -
A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers
|
Phase 1 | |
| Completed |
NCT04210713 -
Neuroimmune Dysfunction in Alcohol Use Disorder
|
Phase 1 | |
| Recruiting |
NCT05132829 -
Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial
|
Phase 4 | |
| Recruiting |
NCT05284318 -
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
|
||
| Completed |
NCT01855048 -
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers
|
Phase 1 |